NEW YORK, Oct. 23 - Proteomics and pharmacogenomics firm Aspira Biosystems has won a Small Business Innovation Research grant from the National Institutes of Health, the company said on Tuesday.

According to South San Francisco, Calif.-based Aspira, the $108,000 award will help it develop a sequence-specific protein chip based on its ProteinPrint technology. This technology, the company said, allows researchers to create “synthetic cavities” that recognize and bind to specific amino-acid sequences.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

A new study in JAMA finds that genetic tests might not be able to determine what diet is right for someone seeking to lose weight.

A genome-wide association study that linked common genetic variants to salivary gland carcinoma risk has been retracted, according to Retraction Watch.

Vampire bats' ability to live off blood is etched in their genomes and gut microbiomes, the Scientist reports.

In Genome Biology this week: peopling of the Sahara, epigenetic reprogramming analysis of liverwort, and more.